Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/CE

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/CE History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/CE(x) 24.2617.9212.225.687.72

What is the latest EV/CE ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/CE ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 24.26 based on Mar2025 Consolidated results.
Year EV/CE
Mar202524.26
Mar202417.92
Mar202312.22
Mar20225.68
Mar20217.72

How is EV/CE of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/CE % Change
Mar2025 24.26
35.38
Mar2024 17.92
46.64
Mar2023 12.22
115.14
Mar2022 5.68
-26.42
Mar2021 7.72 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/CE ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹44,905.4 Cr 3.1% 8.9% 4.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

3.1%

8.9%

4.4%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses